MannKind Corporation Announces Results of 2026 Annual Meeting of Stockholders

MannKind Corporation held its 2026 Annual Meeting of Stockholders on May 20, 2026. During the meeting, stockholders voted on three key proposals. First, all nine director nominees—James S. Shannon, Michael E. Castagna, Steven B. Binder, Ronald J. Consiglio, Michael A. Friedman, Jennifer Grancio, Anthony Hooper, Sabrina Kay, and Christine Mundkur—were elected to serve until the next annual meeting. Second, stockholders approved, on an advisory basis, the compensation of the company's named executive officers as disclosed in the proxy statement filed in April 2026. Finally, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. The filing details the specific vote counts, including shares for, withheld, against, and abstentions, as well as broker non-votes for each proposal. No other significant corporate developments or clinical trial updates were reported in this filing.